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Improving Pneumococcal Vaccination Rates Using Exclusive Clinic
Visits; a Pilot Program
RR Julia, Jr. MD MS, MJ Sither DO MPH, C Bloomfield MD
Lehigh Valley Health Network, Allentown, Pennsylvania

Background/ Introduction
• O
 verlooked during many resident clinic visits are preventative healthcare measures. The perception also exists
that this aspect of care is substandard in a resident clinic. Based on reports generated by internal computer
systems, our resident clinic was noted to have a 13% rate of pneumococcal vaccination, well below network
average (57%) and goal (63%).  Bolstered by successes at other practices in the network, a pilot vaccine fair was
undertaken to assess if our clinic could mass vaccinate its patients.

Current Conditions
• O
 ur Quality Improvement project was initiated upon review of the Lehigh Valley Physician Practice (LVPP)
vaccination rates. When our clinic was compared with other practices within the Lehigh Valley Physicians Group
(LVPG), our pneumococcal vaccine rate was listed as 13.1% for patients over 65
years old. The LVPG average was 57%, and the goal throughout the network is
63%. This data was collected from our old disparate electronic medical records and
aggregated by population management software.  
• Indications for prophylactic vaccination against pneumococcus are separated into
two populations—65 and older and 18-64 who have: chronic health conditions,
compromised immune systems, smokers, asplenia, CSF leak, cochlear implants, and
residents of long term care facilities.
• C
 urrent recommendations from the Advisory Committee on Immunization Practices
have three categories for patients over 65 (Figure 1). Naïve patients >65 years
old should get the 13-valent pneumococcal conjugate vaccine (PCV13), then in 612 months they should receive 23-valent pneumococcal polysaccharide vaccine
(PPSV-23). For patients who have received PPSV-23 after age 65, PCV13 should be
administered greater one year after getting PPSV-23. If the patient received PPSV23 prior to turning 65, they can still receive PCV-13 one year later, but should also
Figure 1: Advisory Committee on
be revaccinated with PPSV-23 five or more years after the first PPSV-23 vaccination. Immunization Practices Guidelines for
Pneumococcal Vaccination of patients
(Annals of Internal Medicine 162(3): 214-23)
older than 65.

AIM Statement
• T o increase the number of LVPP patients 65 and older who are vaccinated against pneumococcus by 15% using a
dedicated immunization fair.

Analysis
• U
 sing a fishbone diagram, potential causes of  unrecorded vaccinations were discussed amongst the residents
and documented. The omissions discussed not only include why patients remained unvaccinated, but potential
delays in recording vaccines, receiving duplicate
vaccines and sources of waste within the practice
and the computer system. The causes were grouped
into six sections: The patients themselves, the
primary resident seeing them in clinic, the residents
who cover results when the patient’s primary
resident is working inpatient, Staff, Outside Sources
and the EMR (Figure 2). These six factors overlap
in the critical aspect that the vaccine, whenever
and wherever it was given, must be recorded in the
patient’s office chart by either a provider or a staff
member. In this pilot study, we wanted to minimize
complexity by focusing on the patients themselves
and the staff and residents who could administer the
Figure 2: Fishbone diagram illustrating possible causes of missing
vaccine.
Pneumococcal Vaccination at Lehigh Valley Physician’s Practice.

Methods
• O
 ur inspiration for the project came from three sources: prior successes in the network with mass vaccination,
Clinic staff undertaking 15 minute blood pressure and blood sugar visits, and the transition to a new Electronic
Medical Record. First, LVHN has undertaken several vaccine drives, most prominent being the annual Dorney
Park drive-through flu clinic. These are well advertised events that draw hundreds of patients every fall. Second,
one or two staff members are dedicated to 15 minute follow ups that focus vital signs like blood pressure and
blood sugar, especially after recent mediction changes are made. These visits minimize disruption in the practice
by off-loading these follow ups from the residents and help deliver efficient, quality care our 5000-plus patients.
Finally, in 2015, our network switched computer systems from Centricity to Epic, leading to widespread delays
as providers familiarized themselves with the new system and patient data was integrated into the new system.
Our goal in this project was minimize the reliance on either EMR and focusing on activities that could be patient
centered. Combining these three different themes led to the decision to create dedicated time for administering
pneumococcal vaccines.

• B
 y utilizing directed calling to unvaccinated patients in our practice as our
advertizement,  as well as offering multiple vaccination times over mutliple
days, we believed that patient care and quality would be maximized and
waste from computer errors and data entry would be minimized. Using the
old patient population management software, a list of 349 patients over 65
who were unvaccinated was generated. At the time of the pilot study, only
PPSV23 was available to our clinic, so attention was focused on patients >
65 years old who where never recorded as vaccinated.
• S elected patients were directly called by residents or staff and asked
scripted questions in English or Spanish (Figure 3). If the patient agreed
to the vaccine, they were offered one of three half-day windows to arrive.
If they declined, they were asked why and the explanation was recorded.
Reasons for declining were anticipated and scripts were developed for
the presumed most likely reasons. Any non-answers were also recorded
separately. Residents were also given the list of patients as a reminder
if they saw the patient during a regular office visit to discuss the
pneumcoccal vaccine.

Results

Figure 3: Process Mapping for calling
unvaccinated patients.

• O
 ur initial efforts to reach out to the unvaccinated led to the discovery of data sharing errors between the prior
office EMR and prior hospital EMR; only pneumococcal vaccinations in the office were recorded in the population
management program. No inpatient vaccinations were transferred to LVPP’s outpatient chart, nor were they recorded
in our population mangement software. This led to short PDSA cycle within the main project resulting in a manual
audit of all 349 patients listed. An additional 59 patients who received pneumcoccal vaccine were discovered through
this audit prior to the initiation of the vaccine fair. With the transition to Epic and its unified inpatient/outpatient chart,
this problem is believed to be resolved at this time.
• In total, 140 patients out of 349 that were labeled as unvaccinated
were called or had their charts amended in some form (Figure 4).
Of these, 8 agreed to be vaccinated and came in to receive the
PPSV-23 vaccine, 2 of these were vaccinated during their regular
office visit. Four patients said no, none gave a reason why they
declined.
• Difficulties were also encountered in contacting patients: 41 voice
mails were left with patients, 16 phone numbers were inaccurate,
3 patients informed us they had changed physicians and 5 patients
had died but were not removed from the patient panel.
• The combination of audited records and new vaccinations led to
Figure 4: Results of pilot vaccine fair for pneumococcal
a substantial increase in vaccination rate: LVPP’s presumed 13%
vaccines at LVPP. The results combine auditing of patient
pneumococcal vaccination rate among those >65 has increased
charts and calling patients listed as unvaccinated.
to 57%. Though not at the network goal of 63%, it is above the
network average of 56%. This shows us that the residents in our clinic can provide effective preventative care.
• Importantly, the days the vaccine fair was offered did not disrupt or delay usual operations of the clinic. Staff were not
overburdened nor removed from other operations  in the clinic.

Follow-up
• T he resident clinic has the logistical capability to undertake a vaccine fair. In regards to preventative care, the
residents in the clinic also have the medical knowledge and ability to perform at a level similar to their counterparts in
independent practice.  Pitfalls were discovered in our Electronic Medical Records, both in regards to data sharing and
accurate patient contact information. By transitioning to a  unified EMR, updating patient contact info with every visit,
and proactively auditing patient charts for transfers and deaths, our clinic is striving to provide “Seamless patient
care” as discussed in the ACP position statement on Electronic Records. (Annals of Internal Medicine. 162(4):301-3)
• We at LVPP plan to continue improving on the vaccine fair concept. We are looking not only to reach the patients we
did not contact in the pilot study, but expanding to those patients in our clinic who are in the indicated group of 19-64
year-olds. We also now have access to the PSV-13 vaccine, and can fully implement the 2014 AICP recommendations
in Figure 1. We are also considering applying the lessons learned in this project by diversifying the vaccine fair
concept to other preventative health measures like Tdap and Zoster vaccines.
• This Quality Improvement project for Pneumococcal vaccinations not only allowed us to enhance our preventative
care for our patients, but it also allowed us to further review and improve upon how our medical records are viewed
and maintained. Through continual improvement processes, we at LVPP strive to deliver excellent patient care and
continue to improve our residents skills as physicians.
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